These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 15826183)

  • 1. Terephthalamide derivatives as mimetics of helical peptides: disruption of the Bcl-x(L)/Bak interaction.
    Yin H; Lee GI; Sedey KA; Rodriguez JM; Wang HG; Sebti SM; Hamilton AD
    J Am Chem Soc; 2005 Apr; 127(15):5463-8. PubMed ID: 15826183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Terphenyl-Based Bak BH3 alpha-helical proteomimetics as low-molecular-weight antagonists of Bcl-xL.
    Yin H; Lee GI; Sedey KA; Kutzki O; Park HS; Orner BP; Ernst JT; Wang HG; Sebti SM; Hamilton AD
    J Am Chem Soc; 2005 Jul; 127(29):10191-6. PubMed ID: 16028929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Terephthalamide derivatives as mimetics of the helical region of Bak peptide target Bcl-xL protein.
    Yin H; Hamilton AD
    Bioorg Med Chem Lett; 2004 Mar; 14(6):1375-9. PubMed ID: 15006365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure and function of benzoylurea-derived alpha-helix mimetics targeting the Bcl-x(L)/Bak binding interface.
    Rodriguez JM; Ross NT; Katt WP; Dhar D; Lee GI; Hamilton AD
    ChemMedChem; 2009 Apr; 4(4):649-56. PubMed ID: 19330783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (alpha/beta+alpha)-peptide antagonists of BH3 domain/Bcl-x(L) recognition: toward general strategies for foldamer-based inhibition of protein-protein interactions.
    Sadowsky JD; Fairlie WD; Hadley EB; Lee HS; Umezawa N; Nikolovska-Coleska Z; Wang S; Huang DC; Tomita Y; Gellman SH
    J Am Chem Soc; 2007 Jan; 129(1):139-54. PubMed ID: 17199293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and modular parallel synthesis of a MCR derived alpha-helix mimetic protein-protein interaction inhibitor scaffold.
    Antuch W; Menon S; Chen QZ; Lu Y; Sakamuri S; Beck B; Schauer-Vukasinović V; Agarwal S; Hess S; Dömling A
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1740-3. PubMed ID: 16427279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and application of an alpha-helix-mimetic scaffold based on an oligoamide-foldamer strategy: antagonism of the Bak BH3/Bcl-xL complex.
    Ernst JT; Becerril J; Park HS; Yin H; Hamilton AD
    Angew Chem Int Ed Engl; 2003 Feb; 42(5):535-9. PubMed ID: 12569483
    [No Abstract]   [Full Text] [Related]  

  • 8. Structure-activity relationships of Bak derived peptides: affinity and specificity modulations by amino acid replacement.
    Frey V; Viaud J; Subra G; Cauquil N; Guichou JF; Casara P; Grassy G; Chavanieu A
    Eur J Med Chem; 2008 May; 43(5):966-72. PubMed ID: 17692431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bcl-X(L) specifically activates Bak to induce swelling and restructuring of the endoplasmic reticulum.
    Klee M; Pimentel-Muiños FX
    J Cell Biol; 2005 Feb; 168(5):723-34. PubMed ID: 15728194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimycin A mimics a cell-death-inducing Bcl-2 homology domain 3.
    Tzung SP; Kim KM; Basañez G; Giedt CD; Simon J; Zimmerberg J; Zhang KY; Hockenbery DM
    Nat Cell Biol; 2001 Feb; 3(2):183-91. PubMed ID: 11175751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photocontrollable peptide-based switches target the anti-apoptotic protein Bcl-xL.
    Kneissl S; Loveridge EJ; Williams C; Crump MP; Allemann RK
    Chembiochem; 2008 Dec; 9(18):3046-54. PubMed ID: 19012295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological activities of new di- and trimeric quinoline derivatives.
    Broch S; Hénon H; Debaud AL; Fogeron ML; Bonnefoy-Bérard N; Anizon F; Moreau P
    Bioorg Med Chem; 2010 Oct; 18(19):7132-43. PubMed ID: 20800501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational design of new class of BH3-mimetics as inhibitors of the Bcl-xL protein.
    Pinto M; Orzaez Mdel M; Delgado-Soler L; Perez JJ; Rubio-Martinez J
    J Chem Inf Model; 2011 Jun; 51(6):1249-58. PubMed ID: 21528891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationale for Bcl-xL/Bad peptide complex formation from structure, mutagenesis, and biophysical studies.
    Petros AM; Nettesheim DG; Wang Y; Olejniczak ET; Meadows RP; Mack J; Swift K; Matayoshi ED; Zhang H; Thompson CB; Fesik SW
    Protein Sci; 2000 Dec; 9(12):2528-34. PubMed ID: 11206074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a potent Bcl-x(L) antagonist based on alpha-helix mimicry.
    Kutzki O; Park HS; Ernst JT; Orner BP; Yin H; Hamilton AD
    J Am Chem Soc; 2002 Oct; 124(40):11838-9. PubMed ID: 12358513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural model of the BCL-w-BID peptide complex and its interactions with phospholipid micelles.
    Denisov AY; Chen G; Sprules T; Moldoveanu T; Beauparlant P; Gehring K
    Biochemistry; 2006 Feb; 45(7):2250-6. PubMed ID: 16475813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rational design and real time, in-cell detection of the proapoptotic activity of a novel compound targeting Bcl-X(L).
    Becattini B; Kitada S; Leone M; Monosov E; Chandler S; Zhai D; Kipps TJ; Reed JC; Pellecchia M
    Chem Biol; 2004 Mar; 11(3):389-95. PubMed ID: 15123268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bak but not Bax is essential for Bcl-xS-induced apoptosis.
    Lindenboim L; Kringel S; Braun T; Borner C; Stein R
    Cell Death Differ; 2005 Jul; 12(7):713-23. PubMed ID: 15861188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-hairpin peptidomimetics: design, structures and biological activities.
    Robinson JA
    Acc Chem Res; 2008 Oct; 41(10):1278-88. PubMed ID: 18412373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical studies of TW-37, a new nonpeptidic small-molecule inhibitor of Bcl-2, in diffuse large cell lymphoma xenograft model reveal drug action on both Bcl-2 and Mcl-1.
    Mohammad RM; Goustin AS; Aboukameel A; Chen B; Banerjee S; Wang G; Nikolovska-Coleska Z; Wang S; Al-Katib A
    Clin Cancer Res; 2007 Apr; 13(7):2226-35. PubMed ID: 17404107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.